ATHERION BIORESEARCH
TEAM
Our Team
We wouldn’t be able to take Atherion Bioresearch to the next level without our incredible team of entrepreneurs who collaborate together to make your project come to life. Our staff runs like a well-oiled machine, offering all of our clients an engaged and efficient approach aimed at making their days easier.
Leadership
Michael Rosol, PhD
Chief Executive Officer
Prior to Atherion, Dr. Rosol served as Chief Medical Officer, Sr. VP, and principal executive officer of Navidea Biopharmaceuticals, a publicly traded pharmaceutical company with an FDA/EMA approved diagnostic product.
Before this, he served in roles as Associate Director in the Clinical and Translational Imaging Group at Novartis and Head of its Translational Imaging Group.
He was also Senior Director of Business Development at Elucid Bioimaging, Inc. in 2015 and CSO of MediLumine, Inc. in 2016.
Dr. Rosol holds a Ph.D. from the Boston University School of Medicine and was a post-doctoral fellow at Harvard Medical School and the Massachusetts General Hospital. He held several faculty appointments at large research universities, including the Mayo Clinic and the University of Southern California Keck School of Medicine.
Erika Eves, CPA
Chief Financial Officer
Before joining Atherion, Ms. Eves served as Navidea Biopharmaceuticals’ Vice President, Finance and Administration from November 2020 to March 2023. Ms. Eves held several roles of increasing responsibility at Navidea beginning in March 1992, including Accounting Clerk, Staff Accountant, Senior Accountant, Controller and Director, Finance and Administration. In addition to directing the financial operations of the company, she was responsible for internal and external financial reporting including all SEC filings, maintaining a system of internal controls, and managing banking and vendor relationships.
Ms. Eves earned a B.S.B.A. in Accounting from The Ohio State University and is a Certified Public Accountant.
Jeffrey Smith, MBA
Chief Business Officer
Prior to joining Atherion, Mr. Smith was at Navidea Biopharmaceuticals from 2012 to 2023, holding various roles up to and including VP of Operations. He also held FP&A leadership roles at Cardinal Health, where he completed several M&A deals in expansion of the company’s PET manufacturing and radiopharmacy footprint.
His professional career began in Operations Management at Bunge Ltd and General Mills Inc.
Mr. Smith earned a Chemical Engineering degree and Economics minor from The Ohio State University, and an M.B.A. with Financial Management emphasis from Ashland University.
